Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient

Iran J Allergy Asthma Immunol. 2023 Oct 29;22(5):504-509. doi: 10.18502/ijaai.v22i5.13999.

Abstract

Most patients with X-linked agammaglobulinemia are susceptible to infections, while some cases also suffer from inflammatory or autoimmune complications. We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.

Keywords: Agammaglobulinemia; Immunomodulators; Neuroinflammatory diseases; Primary immunodeficiency diseases; Therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Agammaglobulinemia* / complications
  • Agammaglobulinemia* / diagnosis
  • Agammaglobulinemia* / drug therapy
  • Combined Modality Therapy
  • Encephalitis* / complications
  • Genetic Diseases, X-Linked* / complications
  • Genetic Diseases, X-Linked* / diagnosis
  • Genetic Diseases, X-Linked* / drug therapy
  • Humans

Supplementary concepts

  • Bruton type agammaglobulinemia